Skip to main content

Remote Job Finders (RJF)

Novartis Makes Potential $750M+ Bet Per Cardiovascular Disease Target in Another Flagship Pact

Flagship Pioneering’s ProFound Therapeutics will use its proprietary technology to mine the expanded proteome for novel cardiovascular therapeutics. Novartis has promised to pay up to $750 million per target, though it has not specified how many targets it will go after.

Thanks, But No Thanks: Biopharmas Hiring Less International Talent

Given today’s available local talent pool, biopharma companies are less likely to turn toward international job candidates, according to a talent acquisition expert. Findings from two recent BioSpace LinkedIn polls underscore the issue.
Scroll to top